NLRP3 and atherosclerosis: In the context of atherosclerosis and, as mentioned above, CCs and ox-LDL act as ‘danger signals’ and cause a reduction in the NLRP3 inflammasome in the presence of statins, while metabolic and diabetic disorders cause an activation of the NLRP3 inflammasome.